Skip to main content
. 2012 Jan 23;30(8):792–799. doi: 10.1200/JCO.2011.37.0171

Table 2.

Toxicity

Toxicity Treatment
BEP (N = 161)
T-BEP (N = 161)
No. of Patients % No. of Patients %
Hematologic toxicity
    Leucocytes < 1.0 × 10 g/L 17 10.6 26 16.1
    Leucocytopenic fever* 16 10 31 19.2
    Platelets < 25 × 10 g/L 5 3.1 5 3.1
Nonhematologic toxicity
    Allergic reaction
        Grades 1-2 15 9.3 30 18.6
        Grades 3-4 0 0 9 5.5
    Fatigue
        Grades 1-2 111 69 103 64
        Grades 3-4 4 2.5 12 7.5
    Stomatitis/mucocitis
        Grades 1-2 57 35.4 72 44.7
        Grades 3-4 4 2.5 15 9.4
    Diarrhea
        Grades 1-2 32 19.9 56 34.8
        Grades 3-4 3 1.9 16 9.9
    Sensory neuropathy
        Grades 1-2 46 28.5 57 35.4
        Grades 3-4 2 1.2 0 0
    Other neurotoxicity
        Grades 1-2 23 14.3 24 14.9
        Grades 3-4 3 1.2 1 0.6
    Nausea
        Grades 1-2 117 72.7 114 70.8
        Grades 3-4 7 4.3 11 6.8

Abbreviations: BEP, bleomycin, etoposide, and cisplatin; T-BEP, paclitaxel–bleomycin, etoposide, and cisplatin.

*

Leucocytes < 2.0 × 10 g/L, temperature > 38°C.

Denotes National Cancer Institute Common Toxicity Criteria version 2.0, worst toxicity reported over all cycles.